PCR‐SSCP ANALYSIS OF THE p53 GENE IN TUMOURS OF THE ADRENAL GLAND
- 1 July 1996
- journal article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 23 (6-7) , 582-583
- https://doi.org/10.1111/j.1440-1681.1996.tb02786.x
Abstract
1. Mutations of the p53 tumour suppressor gene are relatively common in the aetiology of a wide spectrum of tumour types, both sporadic and familial. 2. The majority of mutations of the p53 gene are reported to be in the highly conserved region of exons 5-8. 3. Alterations in exons 4, 5 and 7 of the p53 gene in patients with functional adrenal tumours, including aldosterone-producing adenomas, have recently been described. 4. In the present study PCR-SSCP was used to examine the exons 4-9 of the p53 gene in paired peripheral blood leucocyte and tumour DNA in a variety of adrenal tumours, including aldosterone-producing carcinoma and adenoma (both familial and sporadic), phaeochromocytoma and incidentaloma. 5. No evidence was found for mutations in exons 4-9 of the p53 gene in these varieties of adrenal tumours.Keywords
This publication has 13 references indexed in Scilit:
- Allelic losses on chromosome band 11q13 in aldosterone‐producing adrenal tumorsGenes, Chromosomes and Cancer, 1995
- p53 Protein accumulates in Cushings adenomas and invasive non- functional adenomas [corrected and republished in J Clin Endocrinol Metab 1995 Feb;80(2):4 p following 692]Journal of Clinical Endocrinology & Metabolism, 1994
- Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutationsNature Genetics, 1994
- AN ASSOCIATION OF PRIMARY ALDOSTERONISM AND ADRENALINE-SECRETING PHAEOCHROMOCYTOMAClinical and Experimental Pharmacology and Physiology, 1994
- Mutations of the p53 gene in human functional adrenal neoplasmsJournal of Clinical Endocrinology & Metabolism, 1994
- EVIDENCE THAT PRIMARY ALDOSTERONISM MAY NOT BE UNCOMMON: 12% INCIDENCE AMONG ANTIHYPERTENSIVE DRUG TRIAL VOLUNTEERSClinical and Experimental Pharmacology and Physiology, 1993
- Primary aldosteronism: hypertension with a genetic basisThe Lancet, 1992
- FAMILIAL HYPERALDOSTERONISM TYPE II: FIVE FAMILIES WITH A NEW VARIETY OF PRIMARY ALDOSTERONISMClinical and Experimental Pharmacology and Physiology, 1992
- CLINICAL AND PATHOLOGICAL DIVERSITY OF PRIMARY ALDOSTERONISM, INCLUDING A NEW FAMILIAL VARIETYClinical and Experimental Pharmacology and Physiology, 1991